Rare Disease

Latest News

New DEBRA-Dermaliq Collaboration Targets Enhanced Drug Delivery for Epidermolysis Bullosa
New DEBRA-Dermaliq Collaboration Targets Enhanced Drug Delivery for Epidermolysis Bullosa

May 28th 2025

A new partnership aims to revolutionize topical treatments for epidermolysis bullosa, enhancing patient care with innovative drug delivery technology.

Quoin Receives FDA Clearance for Second Netherton Trial
Quoin Receives FDA Clearance for Second Netherton Trial

May 22nd 2025

Lurie Children’s Becomes First Treatment Center for Zevaskyn Gene Therapy in Patients with RDEB
Lurie Children’s Becomes First Treatment Center for Zevaskyn Gene Therapy in Patients with RDEB

May 15th 2025

Quoin Announces Positive QRX003 Data for Pediatric Peeling Skin Syndrome
Quoin Announces Positive QRX003 Data for Pediatric Peeling Skin Syndrome

May 14th 2025

FDA Approves First Gene Therapy for RDEB
FDA Approves First Gene Therapy for RDEB

April 29th 2025

Video Interviews
Latest CME Events & Activities

More News

© 2025 MJH Life Sciences

All rights reserved.